CYCC - 1.69 Pre-market now at 1.79/1.80 Cyclacel Announces Selection of Recommended Phase 2 Dose for CYC065 and Evidence of Durable Target Engagement and Mcl-1 Biomarker Suppression http://stockcharts.com/c-sc/sc?s=CYCC&p=D&b=5&g=0&i=t50955230924&r=1502108249582 http://stockcharts.com/c-sc/sc?s=CYCC&p=W&b=5&g=0&i=t81737171190&r=1502108221263